Innovative NeuroTechnologies
Company Details
Status: Private
Employees: 1-10
Location:
Irvine, California, United States
Type:
sample
Technology:
sample
sample
sample
About: Innovative NeuroTechnologies, Inc. (INT) is a development-stage biotechnology company operating in “virtual mode” that is currently pursuing a pipeline of novel biologically-based and disease-modifying therapeutic solutions to prevent, delay, or mitigate the underlying dementia or cognitive decline associated with a spectrum of neurodegenerative disorders referred to as tauopathies, which includes:
• Alzheimer’s disease (AD),
• Frontotemporal dementia (FTD or Pick’s disease),
• Chronic traumatic encephalopathy (CTE) or dementia pugilistica,
• Progressive supranuclear palsy (PSP),
• Corticobasal degeneration (CBD),
• Familial form of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), and
• Parkinson's disease dementia (PDD).
The pathology of these seemingly disparate conditions is similar in that they involve dysregulation of the Tau protein and development of neurofibrillary tangles (NFTs), synaptic dysfunction, and/or neuronal loss, which underlie the observed dementia or cognitive deficits. Unfortunately, there are no effective therapies presently available for this spectrum of disorders, and neurodegenerative tauopathies remain a very significant socioeconomic burden and tremendous unmet medical need worldwide.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Innovative NeuroTechnologies | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.